题名 | Amyloid-β but not tau accumulation is strongly associated with longitudinal cognitive decline |
作者 | |
发表日期 | 2024-07 |
发表期刊 | CNS NEUROSCIENCE & THERAPEUTICS 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
关键词 | Alzheimer's disease amyloid-beta cognition function tau accumulation |
其他关键词 | ALZHEIMERS-DISEASE ; DEPOSITION ; PATHOLOGY |
摘要 | Objective: Alzheimer's disease (AD) pathology is featured by the extracellular accumulation of amyloid-beta (A beta) plaques and intracellular tau neurofibrillary tangles in the brain. We studied whether A beta and tau accumulation are independently associated with future cognitive decline in the AD continuum. Methods: Data were acquired from the Alzheimer's Disease Neuroimaging Initiative (ADNI) public database. A total of 1272 participants were selected based on the availability of A beta-PET and CSF tau at baseline and of those 777 participants with follow-up visits. Results: We found that A beta-PET and CSF tau pathology were related to cognitive decline across the AD clinical spectrum, both as potential predictors for dementia progression. Among them, A beta-PET (A + T- subjects) is an independent reliable predictor of longitudinal cognitive decline in terms of ADAS-13, ADNI-MEM, and MMSE scores rather than tau pathology (A - T+ subjects), indicating tau accumulation is not closely correlated with future cognitive impairment without being driven by A beta deposition. Of note, a high percentage of APOE epsilon 4 carriers with A beta pathology (A+) develop poor memory and learning capacity. Interestingly, this condition is not recurrence in terms of the ADNI-MEM domain when adding APOE epsilon 4 status. Finally, the levels of A beta-PET SUVR related to glucose hypometabolism more strongly in subjects with A + T- than A - T+ both happen at baseline and longitudinal changes. Conclusions: In conclusion, A beta-PET alone without tau pathology (A + T-) measure is an independent reliable predictor of longitudinal cognitive decline but may nonetheless forecast different status of dementia progression. However, tau accumulation alone without A beta pathology background (A - T+) was not enough to be an independent predictor of cognitive worsening. |
资助项目 | Natural Science Foundation of Zhejiang Province [LQ23H090007, LZ23H090001, Y19H090059]; National Natural Science Foundation of China [81600977, 82001363, 82271469]; Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang [2023R01002] |
出版者 | WILEY |
ISSN | 1755-5930 |
EISSN | 1755-5949 |
卷号 | 30期号:7 |
DOI | 10.1111/cns.14860 |
页数 | 15 |
WOS类目 | Neurosciences ; Pharmacology & Pharmacy |
WOS研究方向 | Neurosciences & Neurology ; Pharmacology & Pharmacy |
WOS记录号 | WOS:001268407200001 |
收录类别 | SCIE ; SCOPUS ; PUBMED |
URL | 查看原文 |
PubMed ID | 39014268 |
SCOPUSEID | 2-s2.0-85198616316 |
通讯作者地址 | [Wang, XinShi;Xie, Chenglong]Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurol, Wenzhou 325000, Peoples R China. |
Scopus学科分类 | Pharmacology;Psychiatry and Mental Health;Physiology (medical);Pharmacology (medical) |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/216696 |
专题 | 附属第二医院 附属第一医院 阿尔伯塔学院 卓越中心_老年研究院 |
通讯作者 | Wang, XinShi; Xie, Chenglong |
作者单位 | 1.Wenzhou Med Univ, Affiliated Hosp 2, Yuying Childrens Hosp, Ctr Tradit Chinese Med, Wenzhou, Peoples R China; 2.Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurol, Wenzhou 325000, Peoples R China; 3.Wenzhou Med Univ, Alberta Inst, Wenzhou, Zhejiang, Peoples R China; 4.Univ Oslo, Akershus Univ Hosp, Dept Clin Mol Biol, Lorenskog, Norway; 5.Tradit Chinese & Western Med Hosp Wenzhou, Dept Neurol, Wenzhou, Zhejiang, Peoples R China; 6.Oujiang Lab, Wenzhou, Zhejiang, Peoples R China; 7.Wenzhou Med Univ, Inst Aging, Key Lab Alzheimers Dis Zhejiang Prov, Wenzhou, Zhejiang, Peoples R China; 8.Wenzhou Med Univ, Affiliated Hosp 1, Geriatr Med Ctr, Dept Geriatr, Wenzhou, Zhejiang, Peoples R China |
第一作者单位 | 附属第二医院; 第二临床医学院,附属第二医院、育英儿童医院 |
通讯作者单位 | 附属第一医院 |
第一作者的第一单位 | 附属第二医院 |
推荐引用方式 GB/T 7714 | Wang, Wenwen,Huang, Jiani,Qian, Shuangjie,et al. Amyloid-β but not tau accumulation is strongly associated with longitudinal cognitive decline[J]. CNS NEUROSCIENCE & THERAPEUTICS,2024,30(7). |
APA | Wang, Wenwen., Huang, Jiani., Qian, Shuangjie., Zheng, Yi., Yu, Xinyue., ... & Xie, Chenglong. (2024). Amyloid-β but not tau accumulation is strongly associated with longitudinal cognitive decline. CNS NEUROSCIENCE & THERAPEUTICS, 30(7). |
MLA | Wang, Wenwen,et al."Amyloid-β but not tau accumulation is strongly associated with longitudinal cognitive decline".CNS NEUROSCIENCE & THERAPEUTICS 30.7(2024). |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论